HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/3/C512    most recent 00591.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Moody, M. Articles by Traynor-Kaplan, A. E. Search for Related Content PubMed PubMed Citation Articles by Moody, M. Articles by Traynor-Kaplan, A. E.

TRANSLATIONAL PHYSIOLOGY

Inositol polyphosphate derivative inhibits Na⁺ transport and improves fluid dynamics in cystic fibrosis airway epithelia

¹Inologic Inc., Seattle, Washington; ²University of North Carolina, Chapel Hill, North Carolina; ³European Molecular Biology Laboratory, Heidelberg, Germany; ⁴University of California, Davis, California; and ⁵Children's Hospital, Seattle, Washington

Submitted 2 December 2004 ; accepted in final form 22 April 2005

Amiloride-sensitive, epithelial Na⁺ channel (ENaC)-mediated, active absorption of Na⁺ is elevated in the airway epithelium of cystic fibrosis (CF) patients, resulting in excess fluid removal from the airway lumen. This excess fluid/volume absorption corresponds to CF transmembrane regulator-linked defects in ENaC regulation, resulting in the reduced mucociliary clearance found in CF airways. Herein we show that INO-4995, a synthetic analog of the intracellular signaling molecule, D-myo-inositol 3,4,5,6-tetrakisphosphate, inhibits Na⁺ and fluid absorption across CF airway epithelia, thus alleviating this critical pathology. This conclusion was based on electrophysiological studies, fluid absorption, and ²²Na⁺ flux measurements in CF airway epithelia, contrasted with normal epithelia, and on electrophysiological studies in Madin-Darby canine kidney cells and 3T3 cells overexpressing ENaC. The effects of INO-4995 were long-lasting, dose-dependent, and more pronounced in epithelia from CF patients vs. controls. These findings support preclinical development of INO-4995 for CF treatment and demonstrate for the first time the therapeutic potential of inositol polyphosphate derivatives.

epithelial Na⁺ channels; fluid absorption

This article has been cited by other articles:

				L. Yang, J. Reece, S. E. Gabriel, and S. B. Shears Apical localization of ITPK1 enhances its ability to be a modifier gene product in a murine tracheal cell model of cystic fibrosis J. Cell Sci., April 1, 2006; 119(7): 1320 - 1328. [Abstract] [Full Text] [PDF]